In the current study, we aimed to investigate Lp(a) associations with new-onset T2D and NAFLD in the UK Biobank, a large population-based cohort, and examined effect modification by treatment with statin. The gene discussed is LPA; the disease is metabolic dysfunction-associated steatotic liver disease.